Novartis AG (NOVN) Gets a Sell From Barclays
The prospects of European Medical Care stocks are complex, with USA policies and new drug trial results being the key factors.
After falling from a high position in the last few months of 2024, European Medical Care stocks face the risks of US politics and the results of high-risk new drug trials in the new year.
Top Gap Ups and Downs on Wednesday: CI, IBN, EA and More
Express News | CA Governor Newsom Proclaimed State Of Emergency To Further Enhance State's Preparedness And Accelerate The Bird Flu Cross-Agency Response Efforts
Express News | CDC Confirms First Severe Case Of H5N1 Bird Flu In U.S. On December 13; Patient Hospitalized With Severe Case Of Avian Influenza A Virus Infection In Louisiana
BioAge Stock Advances 14% On Novartis Research Collaboration
JimyJimy : can we run this up today
the MONEY drifter : lot of good news with this candidate. It's already on my watchlist today
Stock_Drift OP JimyJimy : Let’s hope so!!
